Literature DB >> 120379

Pathogenesis of mouse scrapie: dynamics of agent replication in spleen, spinal cord and brain after infection by different routes.

R H Kimberlin, C A Walker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 120379     DOI： 10.1016/0021-9975(79)90046-x

Source DB:  PubMed          Journal:  J Comp Pathol        ISSN： 0021-9975            Impact factor:   1.311


× No keyword cloud information.
  58 in total

Review 1.  Prion diseases: current understanding of epidemiology and pathogenesis, and therapeutic advances.

Authors:  Maria Caramelli; Giuseppe Ru; Pierluigi Acutis; Gianluigi Forloni
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

2.  Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease.

Authors:  Tao Pan; Poki Wong; Binggong Chang; Chaoyang Li; Ruliang Li; Shin-Chung Kang; Thomas Wisniewski; Man-Sun Sy
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Efficient lymphoreticular prion propagation requires PrP(c) in stromal and hematopoietic cells.

Authors:  P S Kaeser; M A Klein; P Schwarz; A Aguzzi
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Scrapie: Report of an outbreak and brief review.

Authors:  L Petrie; B Heath; D Harold
Journal:  Can Vet J       Date:  1989-04       Impact factor: 1.008

5.  Accelerated, spleen-based titration of variant Creutzfeldt-Jakob disease infectivity in transgenic mice expressing human prion protein with sensitivity comparable to that of survival time bioassay.

Authors:  Sophie Halliez; Fabienne Reine; Laetitia Herzog; Emilie Jaumain; Stéphane Haïk; Human Rezaei; Jean-Luc Vilotte; Hubert Laude; Vincent Béringue
Journal:  J Virol       Date:  2014-05-21       Impact factor: 5.103

6.  Opposite effects of dextran sulfate 500, the polyene antibiotic MS-8209, and Congo red on accumulation of the protease-resistant isoform of PrP in the spleens of mice inoculated intraperitoneally with the scrapie agent.

Authors:  V Beringue; K T Adjou; F Lamoury; T Maignien; J P Deslys; R Race; D Dormont
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

7.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

8.  Interaction of scrapie agent and cells of the lymphoreticular system.

Authors:  R I Carp; S M Callahan; B A Patrick; P D Mehta
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

9.  Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.

Authors:  Ronald A Shikiya; Thomas E Eckland; Alan J Young; Jason C Bartz
Journal:  Prion       Date:  2014       Impact factor: 3.931

10.  Prion interference is due to a reduction in strain-specific PrPSc levels.

Authors:  Jason C Bartz; Michelle L Kramer; Meghan H Sheehan; Jessica A L Hutter; Jacob I Ayers; Richard A Bessen; Anthony E Kincaid
Journal:  J Virol       Date:  2006-11-01       Impact factor: 5.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.